BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 34573100)

  • 1. Signaling Overlap between the Golgi Stress Response and Cysteine Metabolism in Huntington's Disease.
    Paul BD
    Antioxidants (Basel); 2021 Sep; 10(9):. PubMed ID: 34573100
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cysteine metabolism and hydrogen sulfide signaling in Huntington's disease.
    Paul BD
    Free Radic Biol Med; 2022 Jun; 186():93-98. PubMed ID: 35550919
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Golgi stress response reprograms cysteine metabolism to confer cytoprotection in Huntington's disease.
    Sbodio JI; Snyder SH; Paul BD
    Proc Natl Acad Sci U S A; 2018 Jan; 115(4):780-785. PubMed ID: 29317536
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutant Huntingtin Derails Cysteine Metabolism in Huntington's Disease at Both Transcriptional and Post-Translational Levels.
    Paul BD; Sbodio JI; Snyder SH
    Antioxidants (Basel); 2022 Jul; 11(8):. PubMed ID: 36009188
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Small molecule modulator of protein disulfide isomerase attenuates mutant huntingtin toxicity and inhibits endoplasmic reticulum stress in a mouse model of Huntington's disease.
    Zhou X; Li G; Kaplan A; Gaschler MM; Zhang X; Hou Z; Jiang M; Zott R; Cremers S; Stockwell BR; Duan W
    Hum Mol Genet; 2018 May; 27(9):1545-1555. PubMed ID: 29462355
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endoplasmic reticulum stress: The cause and solution to Huntington's disease?
    Jiang Y; Chadwick SR; Lajoie P
    Brain Res; 2016 Oct; 1648(Pt B):650-657. PubMed ID: 27040914
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impaired Redox Signaling in Huntington's Disease: Therapeutic Implications.
    Paul BD; Snyder SH
    Front Mol Neurosci; 2019; 12():68. PubMed ID: 30941013
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Converging pathways in the occurrence of endoplasmic reticulum (ER) stress in Huntington's disease.
    Vidal R; Caballero B; Couve A; Hetz C
    Curr Mol Med; 2011 Feb; 11(1):1-12. PubMed ID: 21189122
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IRE1 plays an essential role in ER stress-mediated aggregation of mutant huntingtin via the inhibition of autophagy flux.
    Lee H; Noh JY; Oh Y; Kim Y; Chang JW; Chung CW; Lee ST; Kim M; Ryu H; Jung YK
    Hum Mol Genet; 2012 Jan; 21(1):101-14. PubMed ID: 21954231
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cystathionine γ-lyase deficiency mediates neurodegeneration in Huntington's disease.
    Paul BD; Sbodio JI; Xu R; Vandiver MS; Cha JY; Snowman AM; Snyder SH
    Nature; 2014 May; 509(7498):96-100. PubMed ID: 24670645
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of endoplasmic reticulum stress counteracts neuronal cell death and protein aggregation caused by N-terminal mutant huntingtin proteins.
    Reijonen S; Putkonen N; Nørremølle A; Lindholm D; Korhonen L
    Exp Cell Res; 2008 Mar; 314(5):950-60. PubMed ID: 18255062
    [TBL] [Abstract][Full Text] [Related]  

  • 12. AAV-mediated delivery of the transcription factor XBP1s into the striatum reduces mutant Huntingtin aggregation in a mouse model of Huntington's disease.
    Zuleta A; Vidal RL; Armentano D; Parsons G; Hetz C
    Biochem Biophys Res Commun; 2012 Apr; 420(3):558-63. PubMed ID: 22445760
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Towards a comprehensive understanding of the contributions of mitochondrial dysfunction and oxidative stress in the pathogenesis and pathophysiology of Huntington's disease.
    Tobore TO
    J Neurosci Res; 2019 Nov; 97(11):1455-1468. PubMed ID: 31304621
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nucleocytoplasmic trafficking and transcription effects of huntingtin in Huntington's disease.
    Truant R; Atwal RS; Burtnik A
    Prog Neurobiol; 2007 Nov; 83(4):211-27. PubMed ID: 17240517
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Herp Promotes Degradation of Mutant Huntingtin: Involvement of the Proteasome and Molecular Chaperones.
    Luo H; Cao L; Liang X; Du A; Peng T; Li H
    Mol Neurobiol; 2018 Oct; 55(10):7652-7668. PubMed ID: 29430620
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transcriptional control of amino acid homeostasis is disrupted in Huntington's disease.
    Sbodio JI; Snyder SH; Paul BD
    Proc Natl Acad Sci U S A; 2016 Aug; 113(31):8843-8. PubMed ID: 27436896
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Huntingtin is required for ER-to-Golgi transport and for secretory vesicle fusion at the plasma membrane.
    Brandstaetter H; Kruppa AJ; Buss F
    Dis Model Mech; 2014 Dec; 7(12):1335-40. PubMed ID: 25368120
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Downregulation of glial genes involved in synaptic function mitigates Huntington's disease pathogenesis.
    Onur TS; Laitman A; Zhao H; Keyho R; Kim H; Wang J; Mair M; Wang H; Li L; Perez A; de Haro M; Wan YW; Allen G; Lu B; Al-Ramahi I; Liu Z; Botas J
    Elife; 2021 Apr; 10():. PubMed ID: 33871358
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased Steady-State Mutant Huntingtin mRNA in Huntington's Disease Brain.
    Liu W; Chaurette J; Pfister EL; Kennington LA; Chase KO; Bullock J; Vonsattel JP; Faull RL; Macdonald D; DiFiglia M; Zamore PD; Aronin N
    J Huntingtons Dis; 2013; 2(4):491-500. PubMed ID: 25062733
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Loss-of-Huntingtin in Medial and Lateral Ganglionic Lineages Differentially Disrupts Regional Interneuron and Projection Neuron Subtypes and Promotes Huntington's Disease-Associated Behavioral, Cellular, and Pathological Hallmarks.
    Mehler MF; Petronglo JR; Arteaga-Bracho EE; Gulinello ME; Winchester ML; Pichamoorthy N; Young SK; DeJesus CD; Ishtiaq H; Gokhan S; Molero AE
    J Neurosci; 2019 Mar; 39(10):1892-1909. PubMed ID: 30626701
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.